New diabetes clinical trial: Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Published on: March 03, 2024 at 11:00PM
Conditions: Type 2 Diabetes
Interventions: Drug: DA5221-T1; Drug: DA5221-T2; Drug: Placebo; Drug: DA5221-B1; Drug: DA5221-B2
Sponsors: Dong-A ST Co., Ltd.
Not yet recruiting
https://ift.tt/kMKiyWQ